ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: White House Finally Okays Marks To Panel; NCAB Seeks More Data In RFP Announcements

July 2, 1976

NCI Bypass Budget Request For FY 1982Seeks $1.192 Billion; Would Fund 40% Of Competing R01s

May 23, 1980

ACCC Enthusiastically Support New Effort Or Clinical Research

April 3, 1981

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

Senate Committee To Debate Budget Bill Sept. 10; Increase Expected For Breast Cancer Research

September 4, 1992

Mayo Clinic Develops New Jaw Reconstruction Method

August 25, 2006